AAAAAA
Results:
1-8
|
Results: 8
Authors:
Nortvedt, MW
Riise, T
Myhr, KM
Landtblom, AM
Bakke, A
Nyland, HI
Citation: Mw. Nortvedt et al., Reduced quality of life among multiple sclerosis patients with sexual disturbance and bladder dysfunction, MULT SCLER, 7(4), 2001, pp. 231-235
Authors:
Myhr, KM
Riise, T
Vedeler, C
Nortvedt, MW
Gronning, M
Midgard, R
Nyland, HI
Citation: Km. Myhr et al., Disability and prognosis in multiple sclerosis: demographic and clinical variables important for the ability to walk and awarding of disability pension, MULT SCLER, 7(1), 2001, pp. 59-65
Authors:
Nortvedt, MW
Riise, T
Myhr, KM
Nyland, HI
Citation: Mw. Nortvedt et al., Quality of life as a predictor for change in disability in MS - Reply, NEUROLOGY, 56(9), 2001, pp. 1250-1250
Authors:
Nortvedt, MW
Riise, T
Myhr, KM
Nyland, HI
Citation: Mw. Nortvedt et al., Quality of life as a predictor for change in disability in MS, NEUROLOGY, 55(1), 2000, pp. 51-54
Authors:
Nortvedt, MW
Riise, T
Myhr, KM
Nyland, HI
Citation: Mw. Nortvedt et al., Performance of the SF-36, SF-12, and RAND-36 summary scales in a multiple sclerosis population, MED CARE, 38(10), 2000, pp. 1022-1028
Authors:
Nortvedt, MW
Riise, T
Myhr, KM
Nyland, HI
Hanestad, BR
Citation: Mw. Nortvedt et al., Type I interferons and the quality of life of multiple sclerosis patients.Results from a clinical trial on interferon alfa-2a, MULT SCLER, 5(5), 1999, pp. 317-322
Authors:
Nortvedt, MW
Riise, T
Myhr, KM
Nyland, HI
Citation: Mw. Nortvedt et al., Quality of life in multiple sclerosis - Measuring the disease effects morebroadly, NEUROLOGY, 53(5), 1999, pp. 1098-1103
Authors:
Myhr, KM
Riise, T
Lilleas, FEG
Beiske, TG
Celius, EG
Edland, A
Jensen, D
Larsen, JP
Nilsen, R
Nortvedt, MW
Smievoll, AI
Vedeler, C
Nyland, HI
Citation: Km. Myhr et al., Interferon-alpha 2a reduces MRI disease activity in relapsing-remitting multiple sclerosis, NEUROLOGY, 52(5), 1999, pp. 1049-1056
Risultati:
1-8
|